Membranous nephropathy caused by dimercaptosuccinic acid in a patient with Wilson’s disease: a case report and literature review

Membranous nephropathy caused by dimercaptosuccinic acid in a patient with Wilson’s disease: a case report and literature review

Abstract Background Dimercaptosuccinic acid (DMSA) therapy is a kind of chelation therapy for patients with Wilson ‘s disease (WD). While there have been reports of side effects associated with DMSA, the development of membranous nephropathy as a result of this therapy is uncommon. Case presentation...

Full description

Bibliographic Details
Main Authors: Xiang Li, FengXin Hu, Gaosi Xu
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Nephrology
Subjects:
Membranous nephropathy
Dimercaptosuccinic acid
Wilson’s disease
Online Access:https://doi.org/10.1186/s12882-023-03201-6

Similar Items

Similar Items